Envisagenics

Proxima Bio, formerly VantAI, is an AI-native platform for proximity-based drug discovery, mapping protein-protein interactions to design medicines that reshape protein networks rather than inhibit single targets.

Scientific AI can become more useful by learning the mechanisms behind complex systems and using those explanations to guide new investigations.

Output Labs develops AI systems for mechanistic reasoning, aiming to model how complex systems work and apply those explanations to scientific problems.

Drug development can advance faster when clinical assets, operational workflows, and accumulated evidence are coordinated through software rather than fragmented manual processes.

Formation Bio acquires clinical-stage medicines and develops them using an AI-native platform, combining drug selection, trial operations, and reusable data infrastructure.